Showing results (1-10 of 153) with videos related to
Sort By:
Pageof 16
Current Opinion in Oncology|February 24, 2005
Biomarkers for melanomaSima Torabian, Mohammed Kashani-SabetExpert Opinion on Biological Therapy|October 27, 2004
Non-viral delivery of ribozymes for cancer gene therapyMohammed Kashani-SabetThe Journal of Investigative Dermatology. Symposium Proceedings|January 10, 2003
Ribozyme therapeuticsMohammed Kashani-SabetCancer|November 21, 2007
Osteopontin as a molecular prognostic marker for melanomaJavier Rangel, Mehdi Nosrati, Sima Torabian, et al.Current Molecular Medicine|July 23, 2004
Ribozymes in the age of molecular therapeuticsSepideh Bagheri, Mohammed Kashani-SabetClinical & Experimental Metastasis|April 29, 2024
Bromodomain inhibition targeting BPTF in the treatment of melanoma and other solid tumorsImran Khan, Mohammed Kashani-SabetMethods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Immunohistochemical diagnostic and prognostic markers for melanomaMehdi Nosrati, Mohammed Kashani-SabetProceedings of the National Academy of Sciences of the United States of America|April 1, 2009
A multi-marker assay to distinguish malignant melanomas from benign neviMohammed Kashani-Sabet, Javier Rangel, Sima Torabian, et al.Seminars in Cutaneous Medicine and Surgery|July 18, 2009
Melanoma arising in African-, Asian-, Latino- and Native-American populationsBrenda A Shoo, Mohammed Kashani-SabetPageof 16